178 related articles for article (PubMed ID: 4367503)
1. Pathogenesis of peptic ulcer.
Ivey KJ
Aust N Z J Med; 1974 Feb; 4(1):71-4. PubMed ID: 4367503
[No Abstract] [Full Text] [Related]
2. Oral gastric acid secretion-inhibitory activity and anti-ulcer activity of synthetic prostaglandin analogues: C-15 epimers of 15-hydroxy-15-methyl-9-oxoprostanoic acid (AY-22,469).
Lippmann W
Prostaglandins; 1974 Aug; 7(3):223-9. PubMed ID: 4414938
[No Abstract] [Full Text] [Related]
3. Effect of prostaglandins and cyclic AMP on gastric secretion.
Levine R
Ann N Y Acad Sci; 1971 Apr; 180():336-7. PubMed ID: 4329032
[No Abstract] [Full Text] [Related]
4. A study of the effect of saliva on the concentration of mucin in gastric juice and its possible relationship to the aetiology of peptic ulcer.
Malhotra SL
Gut; 1967 Dec; 8(6):548-55. PubMed ID: 6079807
[No Abstract] [Full Text] [Related]
5. Peptic ulcer: a reappraisal of its aetiology.
Wise L
Ann R Coll Surg Engl; 1972 Mar; 50(3):145-63. PubMed ID: 4259236
[No Abstract] [Full Text] [Related]
6. Inhibition of gastric acid secretion and ulcer formation in the rat by orally-administered 11-deoxyprostaglandin analogues: 15-hydroxy-16,16-dimethyl-9-oxoprost-5,13-dienoic acids.
Lippmann W
Prostaglandins; 1974 Aug; 7(3):231-46. PubMed ID: 4413891
[No Abstract] [Full Text] [Related]
7. [The etiopathogenesis and therapy of gastric and duodenal ulcer].
Lattanzi A
Clin Ter; 1978 Sep; 86(6):515-35. PubMed ID: 367685
[No Abstract] [Full Text] [Related]
8. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer].
Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D
Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615
[No Abstract] [Full Text] [Related]
9. Effects of prostaglandins on the stomach and the intestine.
Robert A
Prostaglandins; 1974 Jun; 6(6):523-32. PubMed ID: 4366018
[No Abstract] [Full Text] [Related]
10. Prostaglandins: therapy for peptic ulcer?
Wilson DE
Ann Intern Med; 1973 Aug; 79(2):269-70. PubMed ID: 4580114
[No Abstract] [Full Text] [Related]
11. Inhibition of gastric acid secretion in vitro by prostaglandin E1.
Way L; Durbin RP
Nature; 1969 Mar; 221(5183):874-5. PubMed ID: 4303810
[No Abstract] [Full Text] [Related]
12. Plasma-gastrin and acid secretion in patients with peptic ulceration.
Wesdorp RI; Fischer JE
Lancet; 1974 Oct; 2(7885):857-60. PubMed ID: 4137887
[No Abstract] [Full Text] [Related]
13. Chronic effects of nicotine on rat gastric secretion.
Thompson JH; Spezia CA; Angulo M
Experientia; 1970 Jun; 26(6):615-7. PubMed ID: 4912723
[No Abstract] [Full Text] [Related]
14. The effect of prostaglandin E 1 on the pentagastrin-stimulated gastric secretion in man.
Classen M; Koch H; Bickhardt J; Topf G; Demling L
Digestion; 1971; 4(6):333-44. PubMed ID: 5115089
[No Abstract] [Full Text] [Related]
15. Comparison of the inhibitory effects of tertiary and quaternary compounds on the gastric secretion of rats.
Antonsen S
Acta Pharmacol Toxicol (Copenh); 1967; 25(4):405-19. PubMed ID: 5630678
[No Abstract] [Full Text] [Related]
16. [Prostaglandins and peptic ulcer].
Piqué Badía JM
Med Clin (Barc); 1984 Dec; 83(18):759-61. PubMed ID: 6521539
[No Abstract] [Full Text] [Related]
17. Effect of carbenoxolone on ionic fluxes across normal gastric mucosa and that associated with gastric ulcer.
Ivey KJ; Gray C
Aust N Z J Med; 1973 Oct; 3(5):451-6. PubMed ID: 4591118
[No Abstract] [Full Text] [Related]
18. Significance of local circulatory disturbance in the experimental production of gastric ulcer.
Sekine T; Shiratori T
Tohoku J Exp Med; 1974 Oct; 114(2):121-30. PubMed ID: 4439406
[No Abstract] [Full Text] [Related]
19. Hyperparathyroidism: gastric acid secretion and gastrin.
Dent RI; James JH; Want CA; Deftos LJ; Talamo R; Fischer JE
Ann Surg; 1972 Sep; 176(3):360-9. PubMed ID: 4672461
[No Abstract] [Full Text] [Related]
20. [Gastrin (biochemistry, physiology and clinical importance)].
Bassalyk LS
Ter Arkh; 1970 Dec; 42(12):4-9. PubMed ID: 4929041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
